News tagged with combination
Multiple myeloma patients experience high response rate with new 3-drug combination
Dec 06, 2009 |
not rated yet |
0
A new three-drug combination has shown in a phase 1/2 clinical trial that it is a "highly effective regimen" in the treatment of patients newly diagnosed with multiple myeloma, a cancer of white blood cells in bone marrow, ...
New combination therapy looks promising against ulcer bacteria
Oct 26, 2009 |
not rated yet |
0
Results of a new study reveal that a seven-day course of LOAD therapy is superior to LAC at eliminating the H. pylori bacterium in patients with gastritis and peptic ulcers.
Nanoparticle-based battlefield pain treatment moves a step closer
Nanotechnology / Bio & Medicine
Sep 24, 2009 |
5 / 5 (2) |
0
University of Michigan scientists have developed a combination drug that promises a safer, more precise way for medics and fellow soldiers in battle situations to give a fallen soldier both morphine and a drug that limits ...
Study finds nontuberculous mycobacteria lung disease on the rise in the United States
Sep 24, 2009 |
not rated yet |
0
Nontuberculous mycobacteria (NTM) are environmental organisms found in both water and soil that can cause severe pulmonary (lung) disease in humans. Pulmonary NTM is on the rise in the United States, according to a large ...
Blood test helps guide treatment and can impact quality of life for breast cancer patients
Sep 14, 2009 |
not rated yet |
0
With the goal of tailoring cancer interventions for the individual, researchers at the Lombardi Comprehensive Cancer Center at Georgetown have published the results of a prospective study that validates the use of a simple ...
The hepatitis healing power of blueberry leaves
Aug 07, 2009 |
5 / 5 (6) |
0
A chemical found in blueberry leaves has shown a strong effect in blocking the replication of the Hepatitis C virus, opening up a new avenue for treating chronic HCV infections, which affect 200 million people worldwide and ...
Drug-resistant malaria has emerged in Cambodia
Jul 29, 2009 |
4 / 5 (1) |
2
(PhysOrg.com) -- Malaria parasites in western Cambodia have become resistant to artemisinin-based therapies, the first-line treatment for malaria, according to a study published in the New England Journal of ...
Animal TB 'tracker' to speed drug and vaccine studies
Jul 22, 2009 |
not rated yet |
0
Johns Hopkins researchers have developed a novel way to monitor in real time the behavior of the TB bacterium in mouse lungs noninvasively pinpointing the exact location of Mycobacterium tuberculosis. The ...
New global subsidy for malaria medicines must ensure quality of care
Jul 21, 2009 |
not rated yet |
0
A new subsidy designed to increase access to life-saving antiretrovirals must remain focused on quality patient care if it is to succeed, argues Tido von Schoen-Angerer and colleagues in this week's open access journal PLoS Me ...
Prescribers miss potentially dangerous drug pairs, research shows
Medicine & Health / Medications
Jul 13, 2009 |
5 / 5 (1) |
0
Research led by The University of Arizona College of Pharmacy has found that medication prescribers correctly identified fewer than half of drug pairs with potentially dangerous drug-drug interactions.
Continued vigilance against drug-resistance malaria is needed
Jul 08, 2009 |
not rated yet |
0
Current combination malaria therapies recommended by the World Health Organisation (WHO) provide adequate treatment for mild malaria, according to a Cochrane Systematic Review of the evidence. However, selected trials had ...
Abbott, AstraZeneca seek cholesterol pill approval
Medicine & Health / Medications
Jun 04, 2009 |
4 / 5 (1) |
0
(AP) -- Abbott Laboratories and AstraZeneca PLC on Thursday asked the Food and Drug Administration to approve a drug that combines their cholesterol pills TriLipix and Crestor.
New treatment combination proves safe for head and neck cancer patients
May 31, 2009 |
5 / 5 (1) |
0
Patients undergoing treatment for advanced head and neck cancers may respond well to the addition of gefinitib to chemotherapy, according to a study sponsored by the Eastern Cooperative Oncology Group and chaired by Ethan ...
Triple drug combination is promising option to treat metastatic HER2+ breast cancer
May 15, 2009 |
5 / 5 (1) |
0
Combining two chemotherapy drugs with trastuzumab (Herceptin) to treat women who have metastatic HER2+ breast cancer may offer physicians another choice in their treatment options.
Infants' pain response to immunization varies based on which vaccine is first
May 04, 2009 |
1 / 5 (1) |
0
Infants who receive the pneumococcal conjugate vaccine (PCV) following the combination vaccine for diphtheria, polio, tetanus, pertussis and Haemophilus influenzae type b (DPTaP-Hib vaccine) appear to experience less pain ...
